この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2016/4/181 分で読めます
Hospital and Health System Compounding Under the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or the Agency) is announcing the availability of a draft guidance for industry entitled "Hospital and Health System Compounding Under the Federal Food, Drug, and Cosmetic Act." This guidance describes how FDA intends to apply the Federal Food, Drug, and Cosmetic Act (the FD&C Act) to drugs compounded by licensed pharmacists or physicians in State-licensed hospital or health system pharmacies.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →